Home › NDC Lookup › RxCUI directory › RxCUI 2674934

0.5 ML ixekizumab 80 MG/ML Prefilled Syringe [Taltz] — RxCUI 2674934

Name: 0.5 ML ixekizumab 80 MG/ML Prefilled Syringe [Taltz] (RxCUI 2674934)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic branded drug

RxCUI 2674934 Semantic branded drug · SBD ● Current RxNorm concept 4 FDA products 8 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2674934

Official name0.5 ML ixekizumab 80 MG/ML Prefilled Syringe [Taltz]

Concept typeSemantic branded drug (SBD)

RxNorm statusCurrent RxNorm concept

Also known as0.5 ML Taltz 80 MG/ML Prefilled Syringe; taltz 40 MG in 0.5 ML Prefilled Syringe; Taltz 40 MG per 0.5 ML Prefilled Syringe

FDA products mapped4

Package NDCs mapped8

Reported Medicaid activity (SDUD)72,831 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Ixekizumab Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Taltz is approved to treat moderate-to-severe plaque psoriasis in people 6 years and older, and for adults it also treats psoriatic arthritis, ankylosing spondylitis, and a conditi...
Take Taltz out of the fridge 30 minutes before your injection and let it warm up with the needle cap still on — injecting a cold solution can sting more. Choose a spot on your thig...
How do I give myself the injection, and does it hurt?
Don't just skip a dose without calling your doctor or pharmacist first. Taltz does lower your immune defenses, so your doctor will want to know about any infection — even what feel...

📖 Read our full Ixekizumab Injection guide →

🕸️ Concept Web — How 0.5 ML ixekizumab 80 MG/ML Prefilled Syringe [Ta... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept 0.5 ML ixekizumab 80 MG/ML Prefilled Syringe [Taltz] RxCUI 2674934 Semantic branded drug · SBD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Ixekizumab 1745099 IN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Taltz 1745104 BN
Dose forms 6

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Ixekizumab Prefilled Syringe 1745111 SCDF
- Ixekizumab Injectable Product 1745101 SCDG
- Ixekizumab Prefilled Syringe [Taltz] 1745113 SBDF
- Taltz Injectable Product 1745107 SBDG
- Prefilled Syringe 721656 DF
- Injectable Product 1151126 DFG
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- 0.5 ML ixekizumab 80 MG/ML Prefilled Syringe 2674933 SCD
- Ixekizumab 80 MG/ML 1745100 SCDC
- Ixekizumab 80 MG/ML [Taltz] 1745105 SBDC

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

0.5 ML ixekizumab 80 MG/ML Prefilled Syringe SCD · 2674933
Ixekizumab 80 MG/ML SCDC · 1745100
Ixekizumab Prefilled Syringe SCDF · 1745111
Ixekizumab Injectable Product SCDG · 1745101

Brand-Name Concepts

Ixekizumab 80 MG/ML [Taltz] SBDC · 1745105
Ixekizumab Prefilled Syringe [Taltz] SBDF · 1745113
Taltz Injectable Product SBDG · 1745107
Taltz BN · 1745104

📦 FDA Products & Package NDCs

4 products · 8 package NDCs

8 package NDCs map to RxCUI 2674934 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
00002-1445-09	3 SYRINGE in 1 CARTON (0002-1445-09) / 1 mL in 1 SYRINGE (0...	TALTZ	Eli Lilly and Company	2016-03-22
00002-1445-11	1 SYRINGE in 1 CARTON (0002-1445-11) / 1 mL in 1 SYRINGE (0...	TALTZ	Eli Lilly and Company	2016-03-22
00002-1445-27	2 SYRINGE in 1 CARTON (0002-1445-27) / 1 mL in 1 SYRINGE (0...	TALTZ	Eli Lilly and Company	2016-03-22
00002-1445-61	1 SYRINGE in 1 CARTON (0002-1445-61) / 1 mL in 1 SYRINGE	TALTZ	Eli Lilly and Company	2016-04-19
00002-7724-11	1 SYRINGE in 1 CARTON (0002-7724-11) / 1 mL in 1 SYRINGE (0...	TALTZ	Eli Lilly and Company	2016-03-22
00002-7724-99	1 SYRINGE in 1 CARTON (0002-7724-99) / 1 mL in 1 SYRINGE	TALTZ	Eli Lilly and Company	2018-01-16
00002-8900-11	1 SYRINGE in 1 CARTON (0002-8900-11) / .25 mL in 1 SYRINGE...	TALTZ	Eli Lilly and Company	2024-02-02
00002-8905-11	1 SYRINGE in 1 CARTON (0002-8905-11) / .5 mL in 1 SYRINGE (...	TALTZ	Eli Lilly and Company	2024-02-02

Observed labelers: Eli Lilly and Company (8) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.